463 related articles for article (PubMed ID: 30281618)
1. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa.
Brennan AT; Jamieson L; Crowther NJ; Fox MP; George JA; Berry KM; Stokes A; Maskew M; Sanne I; Long L; Cassim N; Rosen S
PLoS One; 2018; 13(10):e0204020. PubMed ID: 30281618
[TBL] [Abstract][Full Text] [Related]
2. Regimen durability in HIV-infected children and adolescents initiating first-line antiretroviral therapy in a large public sector HIV cohort in South Africa.
Bonawitz R; Brennan AT; Long L; Heeren T; Maskew M; Sanne I; Fox MP
Trop Med Int Health; 2018 Jun; 23(6):650-660. PubMed ID: 29656449
[TBL] [Abstract][Full Text] [Related]
3. Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa.
Onoya D; Hirasen K; van den Berg L; Miot J; Long LC; Fox MP
Drug Saf; 2018 Dec; 41(12):1343-1353. PubMed ID: 30043384
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study.
Rodríguez-Arbolí E; Mwamelo K; Kalinjuma AV; Furrer H; Hatz C; Tanner M; Battegay M; Letang E;
PLoS One; 2017; 12(3):e0172089. PubMed ID: 28273105
[TBL] [Abstract][Full Text] [Related]
5. Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.
Dorward J; Sookrajh Y; Khubone T; van der Molen J; Govender R; Phakathi S; Lewis L; Bottomley C; Maraj M; Lessells RJ; Naidoo K; Butler CC; Van Heerden R; Garrett N
Lancet HIV; 2023 May; 10(5):e284-e294. PubMed ID: 37001536
[TBL] [Abstract][Full Text] [Related]
6. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
[TBL] [Abstract][Full Text] [Related]
8. Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa.
Brennan AT; Bonawitz R; Schnippel K; Berhanu R; Maskew M; Long L; Bassett J; Sanne I; Fox MP
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1040-5. PubMed ID: 27393537
[TBL] [Abstract][Full Text] [Related]
9. Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
Kaplan SR; Oosthuizen C; Stinson K; Little F; Euvrard J; Schomaker M; Osler M; Hilderbrand K; Boulle A; Meintjes G
PLoS Med; 2017 Nov; 14(11):e1002407. PubMed ID: 29112692
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Incident Hypertension Within 1 Year of Initiating Antiretroviral Therapy Among People with HIV.
Siddiqui M; Moore TJ; Long DM; Burkholder GA; Willig A; Wyatt C; Heath S; Muntner P; Overton ET
AIDS Res Hum Retroviruses; 2022 Sep; 38(9):735-742. PubMed ID: 35778856
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk factors among ART-experienced people with HIV in South Africa.
Hyle EP; Bekker LG; Martey EB; Huang M; Xu A; Parker RA; Walensky RP; Middelkoop K
J Int AIDS Soc; 2019 Apr; 22(4):e25274. PubMed ID: 30990252
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
Rohner E; Sengayi M; Goeieman B; Michelow P; Firnhaber C; Maskew M; Bohlius J
Int J Cancer; 2017 Aug; 141(3):488-496. PubMed ID: 28440019
[TBL] [Abstract][Full Text] [Related]
13. Incidence and predictors of hypertension in adults with HIV-initiating antiretroviral therapy in south-western Uganda.
Okello S; Kanyesigye M; Muyindike WR; Annex BH; Hunt PW; Haneuse S; Siedner MJ
J Hypertens; 2015 Oct; 33(10):2039-45. PubMed ID: 26431192
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy.
Karamchand S; Leisegang R; Schomaker M; Maartens G; Walters L; Hislop M; Dave JA; Levitt NS; Cohen K
Medicine (Baltimore); 2016 Mar; 95(9):e2844. PubMed ID: 26945366
[TBL] [Abstract][Full Text] [Related]
15. Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
Brennan AT; Davies MA; Bor J; Wandeler G; Stinson K; Wood R; Prozesky H; Tanser F; Fatti G; Boulle A; Sikazwe I; Wool-Kaloustian K; Yuannoutsos C; Leroy V; de Rekeneire N; Fox MP
AIDS; 2017 Jan; 31(1):147-157. PubMed ID: 27776039
[TBL] [Abstract][Full Text] [Related]
16. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463
[TBL] [Abstract][Full Text] [Related]
17. Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa.
Dawood H; Hassan-Moosa R; Zuma NY; Naidoo K
BMC Infect Dis; 2018 Apr; 18(1):168. PubMed ID: 29636023
[TBL] [Abstract][Full Text] [Related]
18. Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa.
Brennan AT; Maskew M; Ive P; Shearer K; Long L; Sanne I; Fox MP
J Int AIDS Soc; 2013 Nov; 16(1):18794. PubMed ID: 24256692
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
[TBL] [Abstract][Full Text] [Related]
20. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
